While IGF-1 LR3 has shown promise in various research applications, potential side effects include: Hypoglycemia : Low blood sugar levels, which can lead to symptoms like dizziness, sweating, and Confusion Joint and Muscle Pain : Discomfort due to increased tissue growth . Edema : Fluid retention causing swelling in extremities . Organ Enlargement : Potential growth of internal organs with prolonged use . Acromegaly : Abnormal growth of bones and tissues with excessive or prolonged use . Its crucial to monitor for these effects and consult with a healthcare professional during research applications. Is IGF-1 LR3 approved for human use
Toxic megacolontotal or segmental nonobstructive dilatation of the colon with systemic toxicity in patients with IBD or infectious colitis Laboratory values of acute phase reactants, including the erythrocyte sedimentation rate and C- reactive protein, can be increased but may also be normal in mildly active disease
Research-grade Ipamorelin peptide products are intended strictly for laboratory research use only and are not approved for human consumption
topical use is common, and injectable forms should be used under medical guidance
Inflammopharmacol 33 , 29192934 (2025)
Flavan-3-ol structures are characterised by having a B ring attached to C-2, with an absent carbonyl group at C-4 and double bonds between C-2 and C-3 (Reference Hackman, Polagruto and Zhu88)
